v3.26.1
Consolidated Statements of Changes in Stockholders’ Equity (Deficit) - USD ($)
$ in Thousands
Total
At-the-Market Offering
As reported
Preferred Stock
Series A Preferred Stock
Preferred Stock
Series A Preferred Stock
As reported
Preferred Stock
Series B Preferred Stock
Preferred Stock
Series B Preferred Stock
As reported
Common Stock
Class A Common Stock
Common Stock
Class A Common Stock
At-the-Market Offering
Common Stock
Class A Common Stock
As reported
Common Stock
Class A Common Stock
Revision of Prior Period, Adjustment
Additional Paid-in Capital
Additional Paid-in Capital
At-the-Market Offering
Additional Paid-in Capital
As reported
Accumulated Other Comprehensive Income
Accumulated Other Comprehensive Income
As reported
Accumulated Deficit
Accumulated Deficit
As reported
Beginning balance (in shares) at Dec. 31, 2024       167,972 167,972 0 0 328,069   328,436 (367)              
Beginning balance at Dec. 31, 2024 $ (12,896)   $ (12,896) $ 0 $ 0 $ 0 $ 0 $ 0   $ 0   $ 119,487   $ 119,487 $ 227 $ 227 $ (132,610) $ (132,610)
Shares issued for:                                    
Vesting of restricted share units (in shares)               322                    
Proceeds from issuance of common stock (in shares)               43,333                    
Reverse stock split fractional adjustment (in shares)               6                    
Stock compensation 71                     71            
Foreign currency translation 570                           570      
Fixed dividends Preferred Series B (317)                     (317)            
Net loss (3,243)                               (3,243)  
Ending balance (in shares) at Mar. 31, 2025       167,972   0   371,730                    
Ending balance at Mar. 31, 2025 (15,815)     $ 0   $ 0   $ 0       119,241     797   (135,853)  
Beginning balance (in shares) at Dec. 31, 2025       167,972   1,586,620   1,370,010                    
Beginning balance at Dec. 31, 2025 1,255     $ 0   $ 0   $ 0       155,123     2,552   (156,420)  
Shares issued for:                                    
Proceeds from issuance of common stock (in shares)                 2,031,697                  
Proceeds from issuance of common stock   $ 3,682                     $ 3,682          
Stock compensation 32                     32            
Foreign currency translation (138)                           (138)      
Fixed dividends Preferred Series B (317)                     (317)            
Net loss (6,525)                               (6,525)  
Ending balance (in shares) at Mar. 31, 2026       167,972   1,586,620   3,401,707                    
Ending balance at Mar. 31, 2026 $ (2,011)     $ 0   $ 0   $ 0       $ 158,520     $ 2,414   $ (162,945)